Evidence map›Paper›PMID 39392156›Full record

ArticleImmunotherapy2024

Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma.

Omar Elghawy, Adam Barsouk, Reema Patel, Lauren Reed-Guy, John S Wang, Jessica Xu, Austin Yang, Jonathan Sussman, Varinder Kaur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Omar ElghawyHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.ORCID 0000-0002-0786-8035
Adam BarsoukHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.
Reema PatelUniversity of Virginia Health, Department of Internal Medicine, Division of Hematology & Oncology, Charlottesville, VA 22903, USA.
Lauren Reed-GuyHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.
John S WangMcGaw Medical Center of Northwestern University, Department of Internal Medicine, Chicago, IL 60611, USA.
Jessica XuHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.
Austin YangHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.
Jonathan SussmanHospital of the University of Pennsylvania, Department of Internal Medicine, Philadelphia, PA 19104, USA.
Varinder KaurUniversity of Virginia Health, Department of Internal Medicine, Division of Hematology & Oncology, Charlottesville, VA 22903, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Head and Neck NeoplasmsImmune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckAdultAgedAged, 80 and overDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMiddle AgedRetrospective StudiesImmune Checkpoint Inhibitorshead & neck squamous cell carcinomaimmune-checkpoint inhibitor therapyimmune-related adverse eventsipilimumabnivolumabpembrolizumab

Identifiers

PMID39392156
PMCPMC11492630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.